ES521794A0 - Procedimiento de obtencion de compuestos para la preparacion de agentes inhibidores de la agregacion de plaquetas. - Google Patents

Procedimiento de obtencion de compuestos para la preparacion de agentes inhibidores de la agregacion de plaquetas.

Info

Publication number
ES521794A0
ES521794A0 ES521794A ES521794A ES521794A0 ES 521794 A0 ES521794 A0 ES 521794A0 ES 521794 A ES521794 A ES 521794A ES 521794 A ES521794 A ES 521794A ES 521794 A0 ES521794 A0 ES 521794A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
platelet aggregation
inhibiting agents
obtaining compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES521794A
Other languages
English (en)
Other versions
ES8503347A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of ES8503347A1 publication Critical patent/ES8503347A1/es
Publication of ES521794A0 publication Critical patent/ES521794A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES521794A 1982-04-15 1983-04-15 Procedimiento de obtencion de compuestos para la preparacion de agentes inhibidores de la agregacion de plaquetas. Granted ES521794A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/368,863 US4443450A (en) 1982-04-15 1982-04-15 Platelet aggregation inhibitory agents and intermediates therefor

Publications (2)

Publication Number Publication Date
ES8503347A1 ES8503347A1 (es) 1985-03-01
ES521794A0 true ES521794A0 (es) 1985-03-01

Family

ID=23453081

Family Applications (2)

Application Number Title Priority Date Filing Date
ES521794A Granted ES521794A0 (es) 1982-04-15 1983-04-15 Procedimiento de obtencion de compuestos para la preparacion de agentes inhibidores de la agregacion de plaquetas.
ES535122A Granted ES535122A0 (es) 1982-04-15 1984-08-14 Metodo de obtener compuestos utiles como agentes inhibidores de la agregacion de plaquetas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES535122A Granted ES535122A0 (es) 1982-04-15 1984-08-14 Metodo de obtener compuestos utiles como agentes inhibidores de la agregacion de plaquetas

Country Status (12)

Country Link
US (1) US4443450A (es)
EP (1) EP0096735B1 (es)
JP (1) JPS58192869A (es)
AU (1) AU556925B2 (es)
CA (1) CA1256438A (es)
DE (1) DE3380875D1 (es)
DK (1) DK163919C (es)
ES (2) ES521794A0 (es)
GR (1) GR78182B (es)
IE (1) IE55561B1 (es)
IL (1) IL68423A (es)
ZA (1) ZA832584B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798830A (en) * 1982-04-15 1989-01-17 Research Corporation Platelet aggregation inhibitory agents and intermediates therefor
US4994462A (en) * 1982-04-15 1991-02-19 Research Corporation Platelet aggregation inhibitory agents and intermediate therefor
AT392783B (de) * 1987-10-08 1991-06-10 Warner Lambert Co Neue n-substituierte 3-piperidin- oder 3-tetrahydropyridincarbonsaeuren und derivate
JPH0623031U (ja) * 1992-08-25 1994-03-25 青山眼鏡株式会社 眼鏡セット
US6194413B1 (en) * 1995-11-13 2001-02-27 Smithkline Beecham Corporation Hemoregulatory compounds
CN109824704B (zh) * 2019-03-15 2021-01-15 郑州轻工业学院 一种基于Evans-Showell型多酸的金属-有机配合物及其制备方法、应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798070A (en) * 1954-02-04 1957-07-02 Mcneilab Inc Quaternary quinoline carboxamide salts and method of preparing same
BE635597A (es) * 1962-03-01
SE431092B (sv) * 1979-07-10 1984-01-16 Thuresson Af Ekenstam Bo Terapeutiskt aktiva, substituerade piperidinkarboxianilider

Also Published As

Publication number Publication date
DK167083D0 (da) 1983-04-15
AU1341183A (en) 1983-10-20
CA1256438A (en) 1989-06-27
GR78182B (es) 1984-09-26
EP0096735B1 (en) 1989-11-23
DE3380875D1 (en) 1989-12-28
JPH0530828B2 (es) 1993-05-11
US4443450A (en) 1984-04-17
IL68423A (en) 1986-08-31
DK163919C (da) 1992-09-21
AU556925B2 (en) 1986-11-27
ES8503347A1 (es) 1985-03-01
ES8602762A1 (es) 1985-12-16
DK167083A (da) 1983-10-16
JPS58192869A (ja) 1983-11-10
EP0096735A3 (en) 1986-08-20
EP0096735A2 (en) 1983-12-28
IE55561B1 (en) 1990-11-07
ZA832584B (en) 1983-12-28
IE830825L (en) 1983-10-15
ES535122A0 (es) 1985-12-16
DK163919B (da) 1992-04-21

Similar Documents

Publication Publication Date Title
ES522447A0 (es) Procedimiento para la preparacion de 1,4-diceto-pirrollo-3,4-c-pirroles
AR240449A1 (es) Procedimiento para la preparacion de polialquilenpoliaminas no ciclicas.
ES532183A0 (es) Procedimiento para la preparacion de compuestos cefemicos
ES505472A0 (es) Procedimiento para la preparacion de compuestos frugicidas.
AR241017A1 (es) "procedimiento para la preparacion de fenilsilfoniloxibencimidazolcarbamatos sustituidos".
ES520579A0 (es) Procedimiento para la preparacion de eteres oximicos.
NO832659L (no) Fremgangsmaate for fremstilling av antimikrobielle forbindelser.
ES521794A0 (es) Procedimiento de obtencion de compuestos para la preparacion de agentes inhibidores de la agregacion de plaquetas.
ES519529A0 (es) Procedimiento para la preparacion de nuevas tienobenzodiazepinonas sustituidas.
ES520706A0 (es) Procedimiento para la preparacion de sulfonilureas.
ES520537A0 (es) Procedimiento para la preparacion de derivados de carbaciclina.
ES502120A0 (es) Procedimiento para la preparacion de compuestos de viniles- tilbeno
ES521979A0 (es) Procedimiento para la preparacion de disulfuros.
ES519085A0 (es) Procedimiento para la preparacion de compuestos de benzotiazol.
ES522546A0 (es) Procedimiento para la preparacion de nuevos compuestos herbicidas.
ES521331A0 (es) Procedimiento para la preparacion de n-pteridinilureas.
ES526569A0 (es) Procedimiento para la preparacion de alcanolaminoxi-derivados de la 3,4-dihidro-2h-1,4-benzotiazin-3-ona
ES527552A0 (es) Procedimiento para la preparacion de acridanona
ES520986A0 (es) Procedimiento para la preparacion de derivados de 2-piridona.
ES540794A0 (es) Procedimiento para la preparacion de compuestos difluormetoxiaromaticos.
ES519831A0 (es) Procedimiento para la preparacion de disulfuros de (2.2')-ditiazolilo.
ES523098A0 (es) Procedimiento para la preparacion de compuestos de 4-azaftalida
ES517348A0 (es) Procedimiento para la preparacion de n-acetil-tiazolidin-4-carboxilato de hexametilentetramina.
ES520278A0 (es) Procedimiento para la preparacion de derivados bencileterados de pentita.
ES516406A0 (es) "procedimiento para la preparacion de compuestos de triorganoestanohidantoina".

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401